
[ Thu, Sep 23rd 2021 ]: WOPRAI

[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI
[ Wed, Sep 22nd 2021 ]: WOPRAI

[ Tue, Sep 21st 2021 ]: WOPRAI
Difei Yang Maintained (BLUE) at Strong Buy with Decreased Target to $23 on, Sep 22nd, 2021


🞛 This publication is a summary or evaluation of another publication
Difei Yang of Mizuho, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Decreased Target from $29 to $23 on, Sep 22nd, 2021.
Difei has made no other calls on BLUE in the last 4 months.
There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, all agree with Difei's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John Newman of "Canaccord Genuity" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Tuesday, August 10th, 2021
- Salveen Richter of "Goldman Sachs" Downgraded from Strong Buy to Hold and Decreased Target to $23 on, Tuesday, August 10th, 2021
- Yanan Zhu of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $25 on, Tuesday, August 10th, 2021
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $35 on, Friday, July 16th, 2021
- Yun Zhong of "Berenberg" Downgraded from Strong Buy to Hold and Held Target at $35 on, Thursday, July 1st, 2021